Tag Archives: Phase

Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial … – StocksnTrade (registration) (blog)

StocksnTrade (registration) (blog) Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial …StocksnTrade (registration) (blog)A couple of weeks ago, Soligenix Inc (OTCBB:SNGX) reported that it completed patient enrollment as suggested by the Data Review Committee earlier in 2015, into … Continue reading

Posted in OTCBB | Tagged , , , , , , , , , , | Comments Off on Soligenix Inc (OTCBB:SNGX) Completes Enrollment Into Phase II Clinical Trial … – StocksnTrade (registration) (blog)

FONU2 Announces the Successful Completion of the Beta Testing Phase

OTCBB from Google and yahoo

Posted in OTCBB | Tagged , , , , , , | Comments Off on FONU2 Announces the Successful Completion of the Beta Testing Phase

Multi-Family Housing Shows Fragility During Its Recovery Phase

Chicago, IL (PRWEB) August 01, 2013 The U.S. Census Bureau and HUD announced last week that housing starts took a dip in the month of June, an unexpected turn of events as the housing market saw a boost in production … Continue reading

Posted in Stock Market Investing | Tagged , , , , , , | Comments Off on Multi-Family Housing Shows Fragility During Its Recovery Phase

GENSPERA INC : GenSpera Obtains Authorization for G-202 Phase II Trial in the … – 4-traders

GENSPERA INC : GenSpera Obtains Authorization for G-202 Phase II Trial in the …4-tradersGenSpera, Inc. (OTCBB:GNSZ) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) has cleared for initiation a Phase II human clinical … Continue reading

Posted in OTCBB | Tagged , , , , , , | Comments Off on GENSPERA INC : GenSpera Obtains Authorization for G-202 Phase II Trial in the … – 4-traders

QualityStocks News – Access Pharmaceuticals Presents Positive Data of MuGard Phase 4 Clinical Trial at Cancer Symposium

Scottsdale, AZ (PRWEB) June 29, 2012 QualityStocks would like to highlight Access Pharmaceuticals, Inc., a publicly traded biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. The company’s products include MuGard, which … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Comments Off on QualityStocks News – Access Pharmaceuticals Presents Positive Data of MuGard Phase 4 Clinical Trial at Cancer Symposium

Liberty Star Provides Geochem Update Hay Mountain, AZ: Phase I Vegetation Samples Complete, Strong Metal Anomalies …

TUCSON, Ariz.–(BUSINESS WIRE)–Liberty Star Uranium & Metals Corp. (“Liberty Star” or the “Company”) (LBSR: OTCBB) is pleased to provide an update of exploration activity on its Hay Mountain claims. Phase I analysis of assays of vegetation samples taken from the … Continue reading

Posted in OTCBB | Tagged , , , , , , , , , , , , | Comments Off on Liberty Star Provides Geochem Update Hay Mountain, AZ: Phase I Vegetation Samples Complete, Strong Metal Anomalies …

Sorrento Therapeutics Awarded Third Phase I STTR Grant – BioMedReports (subscription)

Sorrento Therapeutics Awarded Third Phase I STTR GrantBioMedReports (subscription)By PR Newswire: Biotechnology SAN DIEGO, June 7, 2012 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTCBB: SRNE) today announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) Fast … Continue reading

Posted in OTCBB | Tagged , , , , , , , , | Comments Off on Sorrento Therapeutics Awarded Third Phase I STTR Grant – BioMedReports (subscription)

Rounder, Inc. (RNDR) Launches Into Virtual World and Social Networking Phase

Tampa, FL & Las Vegas, NV (PRWEB) March 15, 2012 Rounder, Inc. (Rounder or the Company) (RNDR) has moved into a licensing agreement making available the creation of a 3D, user-based, online virtual world that will incorporate social interactions, poker, … Continue reading

Posted in Stock Market Investing | Tagged , , , , , , , , , | Comments Off on Rounder, Inc. (RNDR) Launches Into Virtual World and Social Networking Phase

Aradigm Completes Enrollment In Phase 2b Study Of Inhaled Ciprofloxacin For The Management Of Respiratory Infections …

Aradigm Completes Enrollment In Phase 2b Study Of Inhaled Ciprofloxacin For The Management Of Respiratory Infections … Aradigm Corporation (OTCBB:ARDM) announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company’s inhaled liposomal ciprofloxacin (CFI, … Continue reading

Posted in OTCBB | Tagged , , , , , , , , , | Comments Off on Aradigm Completes Enrollment In Phase 2b Study Of Inhaled Ciprofloxacin For The Management Of Respiratory Infections …